Sarah Parsons
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sarah Parsons has a total of 170 co-authors. Here are the top co-authors by number of shared publications:
- Hans H. de Boer
Victorian Institute of Forensic Medicine, Southbank, Australia
10 shared publications - Mary Noelle Sheppard
Cardiovascular and Genomics Research institute, School of Health & Medical Sciences, City St George’s University of London, United Kingdom (A.A., J.W., E.R.B., M.N.S.).
6 shared publications Matthew Lynch
Victorian Institute of Forensic Medicine, 65 Kavanagh Street, Southbank, VIC 3006, Australia
6 shared publications- Dominica Zentner
Royal Melbourne Hospital
5 shared publications - Katarzyna Michaud
University Center of Legal Medicine Lausanne - Geneva, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
5 shared publications - Andre La Gerche
St Vincent's Institute of Medical Research
4 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Elsevier in Cardiovascular Pathology
- Vol. 86
Recommendations for the examination, processing, and reporting of non-neoplastic pericardial diseases: A consensus statement on pericardial disease from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology
- 6 November 2026
- Published by Elsevier in Cardiovascular Pathology
- Vol. 86
Open AccessRecommendations for the examination, processing, and reporting of non-neoplastic pericardial diseases: A consensus statement on pericardial disease from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology
- Open Access
- 4 November 2026
- Published by Elsevier in Cardiovascular Pathology
- Vol. 86
What is myocyte injury? The histological assessment of lymphocytic myocarditis in autopsy hearts
- 4 November 2026
- Published by Elsevier in Cardiovascular Pathology
- Vol. 86
Open AccessWhat is myocyte injury? The histological assessment of lymphocytic myocarditis in autopsy hearts
- Open Access
Impact of Non‐Uniform Standards in Forensic Postmortem Paediatric Microbiology on the Evidentiary Value of Microbiological Findings: A Scoping Review of Postmortem Sampling Sites, Techniques and Interpretation Methods
To map international literature on the extent, nature and standards of evidence on postmortem microbiology (PMM) sampling in paediatric cases. Investigations of sudden unexpected deaths in infancy and childhood warrant high standards due to their public health and legal significance. PMM is an integral component of these investigations. The review aimed to examine paediatric studies; however, only a single study was identified. The review therefore included articles on PMM of all ages and forensic and clinical autopsies. Data sources used were Medline, Embase, Cochrane CENTRAL and Scopus. Primary studies were selected by title and abstract screening using Covidence. Twenty four primary studies covering 2965 postmortems with an age range of 0–90+ years. There was significant heterogeneity in the selection of sampling sites and interpretation, with no consistent definition for contamination or true infection. There were significant gaps in literature, particularly the lack of paediatric studies, standardised techniques for specimen collection and definition of contamination. An interpretation framework for PMM results was proposed by the authors. These gaps warrant immediate attention as inconsistent interpretation of PMM results can lead to low public confidence in mortality statistics, disease surveillance data and public health policy.
Open AccessImpact of Non‐Uniform Standards in Forensic Postmortem Paediatric Microbiology on the Evidentiary Value of Microbiological Findings: A Scoping Review of Postmortem Sampling Sites, Techniques and Interpretation Methods
To map international literature on the extent, nature and standards of evidence on postmortem microbiology (PMM) sampling in paediatric cases. Investigations of sudden unexpected deaths in infancy and childhood warrant high standards due to their public health and legal significance. PMM is an integral component of these investigations. The review aimed to examine paediatric studies; however, only a single study was identified. The review therefore included articles on PMM of all ages and forensic and clinical autopsies. Data sources used were Medline, Embase, Cochrane CENTRAL and Scopus. Primary studies were selected by title and abstract screening using Covidence. Twenty four primary studies covering 2965 postmortems with an age range of 0–90+ years. There was significant heterogeneity in the selection of sampling sites and interpretation, with no consistent definition for contamination or true infection. There were significant gaps in literature, particularly the lack of paediatric studies, standardised techniques for specimen collection and definition of contamination. An interpretation framework for PMM results was proposed by the authors. These gaps warrant immediate attention as inconsistent interpretation of PMM results can lead to low public confidence in mortality statistics, disease surveillance data and public health policy.
- 8 August 2025
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (9) , 1726-1727
Evidence of absence or absence of evidence? A commentary on ‘Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease’ by Paratz et al.
- 8 August 2025
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (9) , 1726-1727
Evidence of absence or absence of evidence? A commentary on ‘Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease’ by Paratz et al.
- Open Access
- 5 August 2025
- Published by Elsevier in Cardiovascular Pathology
- Vol. 79, 107763
The SCVP and AECVP ‘Seaport criteria’ for lymphocytic myocarditis: Retrospective application to an autopsy cohort
- 5 August 2025
- Published by Elsevier in Cardiovascular Pathology
- Vol. 79, 107763
Open AccessThe SCVP and AECVP ‘Seaport criteria’ for lymphocytic myocarditis: Retrospective application to an autopsy cohort
- Open Access
- 10 July 2025
- Published by Springer Nature in Forensic Science, Medicine and Pathology
- Vol. 22 (1) , 1-6
Post-mortem cardiac-specific troponin-I (cTnI) to determine the cause of non-traumatic hemopericardium
Hemopericardium is regularly seen at autopsy and post-mortem imaging. Once traumatic cases and resuscitation artefact are excluded, hemopericardium is almost always due to either ruptured myocardial infarction or aortic dissection. In this study, we explored whether post-mortem cardiac-specific troponin I (cTnI) can be helpful when autopsy is not feasible and post-mortem imaging findings are inconclusive. Post-mortem cTnI levels were compared between 46 cases with hemopericardium due to ruptured myocardial infarction (RMI), 38 cases of hemopericardium due to aortic dissection (AoD), and 44 cases of natural deaths without hemopericardium (controls). The results showed significantly higher cTnI levels in the RMI group (median 5,821 ng/L) compared to AoD (median 273 ng/L) and controls (median 95 ng/L). Receiver operating characteristic (ROC) analysis indicated that a cTnI threshold of 1,483 ng/L provided the best balance of sensitivity (87%) and specificity (90%) for distinguishing RMI from AoD. Levels of cTnI above 9688 ng/L were exclusively seen in RMI, whilst levels < 250 ng/L excluded this diagnosis. Calculated likelihood ratios demonstrated that higher levels of cTnI favour RMI over AoD, but substantial overlap between the cohorts limited the diagnostic value of intermediate cTnI values. Autopsy remains the gold standard for determining the cause of hemopericardium and cTnI testing is best reserved for cases in which an autopsy is not feasible.
- 10 July 2025
- Published by Springer Nature in Forensic Science, Medicine and Pathology
- Vol. 22 (1) , 1-6
Open AccessPost-mortem cardiac-specific troponin-I (cTnI) to determine the cause of non-traumatic hemopericardium
Hemopericardium is regularly seen at autopsy and post-mortem imaging. Once traumatic cases and resuscitation artefact are excluded, hemopericardium is almost always due to either ruptured myocardial infarction or aortic dissection. In this study, we explored whether post-mortem cardiac-specific troponin I (cTnI) can be helpful when autopsy is not feasible and post-mortem imaging findings are inconclusive. Post-mortem cTnI levels were compared between 46 cases with hemopericardium due to ruptured myocardial infarction (RMI), 38 cases of hemopericardium due to aortic dissection (AoD), and 44 cases of natural deaths without hemopericardium (controls). The results showed significantly higher cTnI levels in the RMI group (median 5,821 ng/L) compared to AoD (median 273 ng/L) and controls (median 95 ng/L). Receiver operating characteristic (ROC) analysis indicated that a cTnI threshold of 1,483 ng/L provided the best balance of sensitivity (87%) and specificity (90%) for distinguishing RMI from AoD. Levels of cTnI above 9688 ng/L were exclusively seen in RMI, whilst levels < 250 ng/L excluded this diagnosis. Calculated likelihood ratios demonstrated that higher levels of cTnI favour RMI over AoD, but substantial overlap between the cohorts limited the diagnostic value of intermediate cTnI values. Autopsy remains the gold standard for determining the cause of hemopericardium and cTnI testing is best reserved for cases in which an autopsy is not feasible.
- Open Access
- 23 May 2025
- Published by Springer Nature in International journal of legal medicine
- Vol. 139 (5) , 1-10
Cardiac-specific troponin-I (cTnI) in a post-mortem setting
Cardiac-specific troponin (cTn) is widely used in clinical medicine to support a diagnosis of acute myocardial infarction. Several studies have explored the value of cTn testing in deceased individuals. These studies suggest that -although there are important limitations associated with its use- post-mortem cTn can be useful in selected cases. A decision for post-mortem cTn testing should however be influenced by factors that have not been explored in much detail. This includes the success rate of post-mortem cTn testing, and whether cTn levels are stable after death. Therefore, this study addresses the post-mortem availability and stability of cardiac-specific Troponin I (cTnI). Post-mortem availability was determined by analysing the success rate in 250 high-sensitivity (hs-)cTnI tests on post-mortem blood samples, and its relationship with variables such as sample location, sample type, post-mortem interval, and decomposition. Post-mortem stability was explored by comparing post-mortem cTnI levels between two samples from the same individual, taken at different times. Post-mortem hs-cTnI tests were successful in 86.4% of cases (216/250), with little effect of sex, age, or cardiopulmonary resuscitation. Visible decomposition precluded a successful test. Other variables associated with decomposition (such as increased post-mortem interval) also affected test success negatively. Our results furthermore suggest that cTnI is very unstable post-mortem, with marked differences in hs-cTnI test results between samples from the same individual. The differences were large (on average 18734 ng/L) and not unidirectional. Instability appeared to increase with larger time intervals, but the results were overall erratic and difficult to interpret. We conclude that hs-cTnI testing results are generally available in a post-mortem setting, but that testing should be performed on the earliest available blood sample. Samples from decomposed individuals should not be tested. Furthermore, the severe instability of cTnI indicates that any post-mortem hs-cTnI result must be interpreted with caution.
- 23 May 2025
- Published by Springer Nature in International journal of legal medicine
- Vol. 139 (5) , 1-10
Open AccessCardiac-specific troponin-I (cTnI) in a post-mortem setting
Cardiac-specific troponin (cTn) is widely used in clinical medicine to support a diagnosis of acute myocardial infarction. Several studies have explored the value of cTn testing in deceased individuals. These studies suggest that -although there are important limitations associated with its use- post-mortem cTn can be useful in selected cases. A decision for post-mortem cTn testing should however be influenced by factors that have not been explored in much detail. This includes the success rate of post-mortem cTn testing, and whether cTn levels are stable after death. Therefore, this study addresses the post-mortem availability and stability of cardiac-specific Troponin I (cTnI). Post-mortem availability was determined by analysing the success rate in 250 high-sensitivity (hs-)cTnI tests on post-mortem blood samples, and its relationship with variables such as sample location, sample type, post-mortem interval, and decomposition. Post-mortem stability was explored by comparing post-mortem cTnI levels between two samples from the same individual, taken at different times. Post-mortem hs-cTnI tests were successful in 86.4% of cases (216/250), with little effect of sex, age, or cardiopulmonary resuscitation. Visible decomposition precluded a successful test. Other variables associated with decomposition (such as increased post-mortem interval) also affected test success negatively. Our results furthermore suggest that cTnI is very unstable post-mortem, with marked differences in hs-cTnI test results between samples from the same individual. The differences were large (on average 18734 ng/L) and not unidirectional. Instability appeared to increase with larger time intervals, but the results were overall erratic and difficult to interpret. We conclude that hs-cTnI testing results are generally available in a post-mortem setting, but that testing should be performed on the earliest available blood sample. Samples from decomposed individuals should not be tested. Furthermore, the severe instability of cTnI indicates that any post-mortem hs-cTnI result must be interpreted with caution.
- 21 April 2025
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 34 (6) , 613-618
A Study of Sudden Cardiac Death in Schizophrenia
- 21 April 2025
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 34 (6) , 613-618
A Study of Sudden Cardiac Death in Schizophrenia
- Open Access
- 2 April 2025
- Published by Springer Nature in International journal of legal medicine
- Vol. 139 (4) , 1579-1596
Ischemic and non-ischemic myocardial injuries at autopsy- an overview for forensic pathologists
Cardiovascular diseases are major causes of morbidity and death worldwide, and most cardiac deaths are related to ischemic injury of the myocardium (myocardial infarction). As underlined in the current clinical definition and classification of myocardial infarctions, not all myocardial injuries are due to ischemia: irreversible injury, ending in necrosis, can be induced also by various other factors, such as infections, immune disorders, physical and chemical agents, and trauma. This is supported by clinical studies showing that elevated serum levels of cardiac troponins, as a measure of myocardial damage, are also a common finding in the non-ischemic types of myocardial injury. Forensic pathologists confronted with autopsy findings suggestive of myocardial injury should therefore realize that both ischemic and non-ischemic forms of myocardial death can be observed, and not only in natural but also non-natural deaths (intoxications, asphyxia, traumatic and iatrogenic deaths, and others). Distinguishing these different types of injuries and underlying diseases or circumstances of death is critical, not only to determine the cause and mechanism of death, but also to help investigate often challenging medico-legal scenarios. This article reviews the broad spectrum of ischemic and non-ischemic myocardial injuries in natural and violent deaths. From this perspective we propose a diagnostic approach to myocardial injuries in a forensic pathology context.
- 2 April 2025
- Published by Springer Nature in International journal of legal medicine
- Vol. 139 (4) , 1579-1596
Open AccessIschemic and non-ischemic myocardial injuries at autopsy- an overview for forensic pathologists
Cardiovascular diseases are major causes of morbidity and death worldwide, and most cardiac deaths are related to ischemic injury of the myocardium (myocardial infarction). As underlined in the current clinical definition and classification of myocardial infarctions, not all myocardial injuries are due to ischemia: irreversible injury, ending in necrosis, can be induced also by various other factors, such as infections, immune disorders, physical and chemical agents, and trauma. This is supported by clinical studies showing that elevated serum levels of cardiac troponins, as a measure of myocardial damage, are also a common finding in the non-ischemic types of myocardial injury. Forensic pathologists confronted with autopsy findings suggestive of myocardial injury should therefore realize that both ischemic and non-ischemic forms of myocardial death can be observed, and not only in natural but also non-natural deaths (intoxications, asphyxia, traumatic and iatrogenic deaths, and others). Distinguishing these different types of injuries and underlying diseases or circumstances of death is critical, not only to determine the cause and mechanism of death, but also to help investigate often challenging medico-legal scenarios. This article reviews the broad spectrum of ischemic and non-ischemic myocardial injuries in natural and violent deaths. From this perspective we propose a diagnostic approach to myocardial injuries in a forensic pathology context.